rs35898375

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000251.3(MSH2):​c.339G>A​(p.Lys113Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.005 in 1,609,290 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.0031 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0052 ( 31 hom. )

Consequence

MSH2
NM_000251.3 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:31

Conservation

PhyloP100: 0.932

Publications

13 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 2-47408528-G-A is Benign according to our data. Variant chr2-47408528-G-A is described in ClinVar as Benign. ClinVar VariationId is 36576.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
Synonymous conserved (PhyloP=0.932 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00308 (468/152106) while in subpopulation NFE AF = 0.00515 (350/67994). AF 95% confidence interval is 0.0047. There are 0 homozygotes in GnomAd4. There are 198 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 31 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.339G>Ap.Lys113Lys
synonymous
Exon 2 of 16NP_000242.1P43246-1
MSH2
NM_001406674.1
c.339G>Ap.Lys113Lys
synonymous
Exon 2 of 18NP_001393603.1
MSH2
NM_001406631.1
c.339G>Ap.Lys113Lys
synonymous
Exon 2 of 18NP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.339G>Ap.Lys113Lys
synonymous
Exon 2 of 16ENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.339G>Ap.Lys113Lys
synonymous
Exon 2 of 16ENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.339G>Ap.Lys113Lys
synonymous
Exon 2 of 17ENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.00307
AC:
467
AN:
151988
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00513
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00294
AC:
738
AN:
251286
AF XY:
0.00297
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00194
Gnomad NFE exome
AF:
0.00488
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00520
AC:
7572
AN:
1457184
Hom.:
31
Cov.:
31
AF XY:
0.00500
AC XY:
3624
AN XY:
725212
show subpopulations
African (AFR)
AF:
0.000749
AC:
25
AN:
33386
American (AMR)
AF:
0.00174
AC:
78
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00161
AC:
42
AN:
26090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39626
South Asian (SAS)
AF:
0.000975
AC:
84
AN:
86120
European-Finnish (FIN)
AF:
0.00187
AC:
100
AN:
53408
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5710
European-Non Finnish (NFE)
AF:
0.00624
AC:
6909
AN:
1107950
Other (OTH)
AF:
0.00543
AC:
327
AN:
60186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
309
619
928
1238
1547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00308
AC:
468
AN:
152106
Hom.:
0
Cov.:
31
AF XY:
0.00266
AC XY:
198
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00157
AC:
65
AN:
41508
American (AMR)
AF:
0.00164
AC:
25
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10570
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00515
AC:
350
AN:
67994
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00471
Hom.:
3
Bravo
AF:
0.00338
Asia WGS
AF:
0.000289
AC:
1
AN:
3476
EpiCase
AF:
0.00535
EpiControl
AF:
0.00492

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
not specified (11)
-
1
6
Lynch syndrome 1 (7)
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
4
Lynch syndrome (4)
-
-
3
not provided (3)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
7.8
DANN
Benign
0.39
PhyloP100
0.93
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35898375; hg19: chr2-47635667; API